AlzeCure Pharma has presented compelling new clinical data on its lead pain candidate, ACD440, at the NeuPSIG 2025 international...
Read MoreResolution Therapeutics has announced a major step forward in the fight against end-stage liver disease, with the first patient...
Read MoreFriends of Cancer Research has announced a landmark collaboration with global clinical research organisation MMS to advance how interim...
Read MoreNovartis has announced positive results from a pivotal phase 3 trial investigating its experimental drug ianalumab in patients with...
Read MoreIn a move that could reshape the landscape of cancer diagnostics, ANGLE has announced a strategic collaboration with Myriad...
Read MoreUpperton Pharma Solutions has secured funding under the first VaxHub Sustainable Platform Funding Call to support the development of...
Read More